Read + Share
Quintela-Fandino M, Holgado E, Manso L, Morales S, et al. Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast
cancer: a pilot clinical trial. Breast Cancer Res 2020;22:124.
PMID: 33176887
|
 |
|
Quintela-Fandino M, Holgado E, Manso L, Morales S, et al. Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast
cancer: a pilot clinical trial. Breast Cancer Res 2020;22:124.
PMID: 33176887
|
|
|
|